HEPION PHARMACEUTICALS, INC. Acquisitions, Net of Cash Acquired
HEPION PHARMACEUTICALS, INC. (HEPA) reported Acquisitions, Net of Cash Acquired of $495.60 thousand for the 12-month period ending 2016-06-30, per its 10-KT filed 2018-03-26.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2018-03-26
- HEPION PHARMACEUTICALS, INC. payments to acquire businesses, net of cash acquired for fiscal 2016 was $495.60K.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|
| 2016-06-30 | $495.60K 10-KT · filed 2018-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |